| |
| |
|
| Insider
Information: |
Domzalski David |
| Relationship: |
|
| City: |
Rehovot |
| State: |
L3 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
494,160 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$110,445 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
494,160 |
|
|
| Total
Value |
$110,445 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
0.0
|
| Percentage
Gain/Loss : |
 -26.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Foamix Pharmaceuticals Ltd |
FOMX |
CEO, Director |
2020-03-09 |
0 |
2018-01-01 |
0 |
Premium* |
|
|
VYNE Therapeutics Inc |
VYNE |
|
2024-04-01 |
494,160 |
2020-03-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
55 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
• • – |
2018-05-08 |
4 |
A |
$0.00 |
$0 |
D/D |
23,396 |
163,150 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
• • – |
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
73,282 |
219,691 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
• • – |
2019-11-29 |
4 |
A |
$2.16 |
$21,249 |
D/D |
9,842 |
218,826 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
• • – |
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
103,248 |
319,323 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
• • – |
2020-03-02 |
4 |
A |
$2.68 |
$12,598 |
D/D |
4,705 |
324,028 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2020-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
191,952 |
191,952 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2020-04-03 |
4 |
A |
$0.00 |
$0 |
D/D |
391,489 |
578,985 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2020-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
680,000 |
1,247,213 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2020-11-30 |
4 |
A |
$1.45 |
$6,160 |
D/D |
4,263 |
1,313,990 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2021-02-22 |
4 |
A |
$0.00 |
$0 |
D/D |
153,750 |
479,833 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2021-05-28 |
4 |
A |
$3.36 |
$3,159 |
D/D |
941 |
474,458 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2021-09-02 |
4 |
A |
$0.00 |
$0 |
D/D |
320,312 |
775,911 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2021-11-30 |
4 |
A |
$0.88 |
$4,119 |
D/D |
4,705 |
767,520 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2022-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
312,302 |
1,072,935 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2022-05-31 |
4 |
A |
$0.35 |
$4,116 |
D/D |
11,887 |
1,061,636 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2022-11-30 |
4 |
A |
$0.20 |
$6,861 |
D/D |
34,705 |
1,074,975 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2023-05-31 |
4 |
A |
$3.46 |
$9,560 |
D/D |
2,766 |
53,414 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2023-11-30 |
4 |
A |
$2.81 |
$6,426 |
D/D |
2,284 |
46,168 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2023-12-13 |
4 |
A |
$0.00 |
$0 |
D/D |
225,000 |
271,168 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2024-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
225,000 |
496,168 |
0 |
- |
|
| VYNE |
VYNE Therapeutics Inc |
President and CEO |
• • – |
2020-09-08 |
4 |
B |
$1.38 |
$103,568 |
D/D |
75,000 |
1,315,966 |
2.81 |
% |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
• • – |
2018-01-02 |
4 |
D |
$5.98 |
$14,334 |
D/D |
(2,397) |
140,422 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
• • – |
2019-09-30 |
4 |
D |
$3.07 |
$6,926 |
D/D |
(2,256) |
208,984 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
• • – |
2019-12-31 |
4 |
D |
$3.28 |
$9,023 |
D/D |
(2,751) |
216,075 |
0 |
- |
|
| FOMX |
Foamix Pharmaceuticals Lt... |
CEO |
• • – |
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(324,028) |
0 |
0 |
- |
|
55 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
